These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A stepwise approach to the management of metastatic midgut carcinoid tumor. Bhattacharyya S; Gujral DM; Toumpanakis C; Dreyfus G; Davidson BR; Davar J; Caplin ME Nat Rev Clin Oncol; 2009 Jul; 6(7):429-33. PubMed ID: 19561636 [TBL] [Abstract][Full Text] [Related]
43. Climacteric flushing in a patient with carcinoid tumour. Wilkin JK Br J Dermatol; 1985 Mar; 112(3):357-61. PubMed ID: 3978040 [TBL] [Abstract][Full Text] [Related]
44. [A neural-endocrine enteropathy]. Benda L Wien Z Inn Med; 1967; 48(9):335-8. PubMed ID: 5620788 [No Abstract] [Full Text] [Related]
45. The use of chromogranin, synaptophysin and islet amyloid polypeptide as markers for neuroendocrine tumours. Stridsberg M Ups J Med Sci; 1995; 100(3):169-99. PubMed ID: 8808182 [No Abstract] [Full Text] [Related]
46. Dramatic response of a metastatic carcinoid tumour to a combination of interferon and octreotide. Joensuu H; Kätkä K; Kujari H Acta Endocrinol (Copenh); 1992 Feb; 126(2):184-5. PubMed ID: 1371898 [TBL] [Abstract][Full Text] [Related]
47. Inhibitory effects of ranitidine on flushing and serum serotonin concentrations in carcinoid syndrome. Noppen M; Jacobs A; Van Belle S; Herregodts P; Somers G Br Med J (Clin Res Ed); 1988 Mar; 296(6623):682-3. PubMed ID: 3128368 [No Abstract] [Full Text] [Related]
48. Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement. Adaway JE; Dobson R; Walsh J; Cuthbertson DJ; Monaghan PJ; Trainer PJ; Valle JW; Keevil BG Ann Clin Biochem; 2016 Sep; 53(Pt 5):554-60. PubMed ID: 26438520 [TBL] [Abstract][Full Text] [Related]
50. [Diagnosis and treatment of primary hepatic carcinoid tumor]. Li T; Qin LX; Pan Q; Pang JZ; Wang L; Sun HC; Ye QH; Fan J; Tang ZY Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1335-7. PubMed ID: 18241569 [TBL] [Abstract][Full Text] [Related]
51. Radioiodinated metaiodobenzylguanidine in the diagnosis and therapy of carcinoid tumors. Khan MU; Morse M; Coleman RE Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):441-54. PubMed ID: 19088697 [TBL] [Abstract][Full Text] [Related]
57. Growling, flushing, and a 30-pound weight loss. Khokhar N Hosp Pract (Off Ed); 1985 Sep; 20(9A):64-5. PubMed ID: 2411744 [No Abstract] [Full Text] [Related]
58. Ghost carcinoid in a patient with 120-fold elevated 5-hydroxyindoacetic acid. Yu R; Wolin E Endocr Pract; 2012; 18(5):803-4. PubMed ID: 23047932 [No Abstract] [Full Text] [Related]
59. Tubulovillous adenoma of the duodenum: a new etiology for flushing and urinary 5-HIAA elevation. Betchen SA; Cirigliano M; Furth EE; Broussard D; Grippi M; Lichtenstein GR Dig Dis Sci; 1998 Jul; 43(7):1474-81. PubMed ID: 9690381 [No Abstract] [Full Text] [Related]
60. Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue. Manfredi S; Pagenault M; de Lajarte-Thirouard AS; Bretagne JF Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):1021-5. PubMed ID: 18049175 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]